What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?

What factors prompt you to offer adjuvant RT? What would be included in your field? Is elective mediastinal RT still used? Assume initial imaging was negative for nodes and surgical mediastinal evaluation was negative.

Answer from: Radiation Oncologist at Academic Institution

I am unaware of any data suggesting a benefit of adjuvant RT in this scenario assuming completely resected. In the absence of data, I would not recommend adjuvant RT in an N1 patient, rationale below. Adjuvant systemic therapy would be strongly recommended. My thought process to this is that SCLC h...

Comments

Radiation Oncologist at Quillen VA Medical Center
There are no lung post op trials showing a benefit...

Answer from: Radiation Oncologist at Community Practice

This was thought to be an early-stage disease (T1-T2N0M0) and the decision was made to undergo lobectomy + hilar/mediastinal LN assessment. This is certainly an option based on NCCN guidelines. After surgery, there was an occult N1 node seen on the path. These patients are still at very high risk of...

Please select the option that best describes you:

What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?

Related Questions